Results 81 to 90 of about 21,888 (191)

Impact of Proton Pump Inhibitor Use on Outcomes Following Carotid Artery Stenting for Asymptomatic Carotid Stenosis: A Population‐Based Cohort Study

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 8, August 2026.
ABSTRACT Carotid artery stenting (CAS) is an effective treatment for carotid stenosis. Proton‐pump inhibitors (PPIs) are commonly prescribed in the general population. However, the impact of PPI use on outcomes following CAS remains unknown. This study investigated the impact of PPI use on CAS using a retrospective, matched‐cohort analysis from the ...
Chia‐En Wong, Pang‐Shuo Perng, Pei‐Wen Chen, Yu Chang, Chih‐Hao Tien, Jung‐Shun Lee, Liang‐Chao Wang, Chih‐Yuan Huang   +7 more
wiley   +1 more source

Advances in Pharmacological Therapy of Benign Tracheal Stenosis: A Meta‐Analysis of Preclinical Studies

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Background Benign tracheal stenosis, characterized by granulation hyperplasia, is a rare and serious disease threatening human health. Interventional bronchoscopy demonstrates limited therapeutic efficacy and poses a risk of re‐injury to the airway.
Dengyuan Li, Jie Zeng, Rufang Li, Rong Wang, Danxiong Sun   +4 more
wiley   +1 more source

Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?

VIEW Medicine, Volume 1, Issue 1, August 2026.
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda, Tatsuya Watanabe, Satoshi Yuhara, John M. Kelly, Hirotsugu Kurobe, Toshiharu Shinoka   +5 more
wiley   +1 more source

Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management

European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.
As transcatheter treatment expands to younger and lower‐risk patients, aortic stenosis management is evolving from a single procedure to lifelong valve care. This review highlights the key challenges across the patient journey, from timely diagnosis and optimal intervention to durable valve performance, long‐term surveillance, and repeat intervention ...
Ottavia Cozzi, Thomas Pilgrim
wiley   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

European Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli, Stefano Fumagalli, Tiziana Cristina Minopoli, Silvia Menale, Valentina Scheggi, Niccolò Marchionni   +5 more
doaj   +1 more source

Assessment of Plaque Characteristics by Contrast-Enhanced Ultrasound and Stent Restenosis following Carotid Artery Stenting: A Retrospective Study

Medicina
Background and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė, Donatas Inčiūra, Gintautė Diringytė, Saulius Lukoševičius, Rytis Kaupas, Andrius Pranculis, Aistė Mačiulaitytė, Algidas Basevičius, Milda Kuprytė, Edgaras Stankevičius, Jurgita Plisienė   +10 more
doaj   +1 more source

Restenosis risk factors after coronary stenting in metabolic syndrome patients

Кардиоваскулярная терапия и профилактика, 2007
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova   +3 more
doaj  

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

Inflammation and In-Stent Restenosis [PDF]

Angiology, 2017
openaire   +2 more sources

Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1

Journal of Materials Science: Materials in Medicine
In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis.
Jiabing Huang, Bingjian Liu, Chunguang Zhao, Jing Li, Dongxu Qiu   +4 more
doaj   +1 more source